ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Top Brokers

More Brokers

Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
Sign In Premium IconPremium Help Menu
FTSE 100
8,164.12
-0.19%
Dow Jones
39,118.86
-0.12%
Gold vs US Dollar
2,326.73
0.00%
Brent Oil
84.85
0.00%
Bitcoin
60,896.64
0.97%
Pepperstone
Advertisement
Registration Strip Icon for charts Register for streaming realtime charts, analysis tools, and prices.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NASDAQ
  6. Rallybio Holdings LLC (RLYB)

  7. Rallybio Holdings LLC (RLYB) News

Rallybio (RLYB)

Rallybio Holdings LLC
Date:
Sort by:
 Showing the most relevant articles for your search:NASDAQ:RLYB
DateTimeSourceHeadlineSymbolCompany
17/06/202413:00Business WireRallybio Announces Results of Epidemiological Analysis Demonstrating FNAIT Risk Across Racially and Ethnically Diverse PopulationsNASDAQ:RLYBRallybio Holdings LLC
21/05/202421:22Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLYBRallybio Holdings LLC
21/05/202405:15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:RLYBRallybio Holdings LLC
17/05/202422:05Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLYBRallybio Holdings LLC
17/05/202422:03Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLYBRallybio Holdings LLC
10/05/202421:02Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:RLYBRallybio Holdings LLC
09/05/202421:09Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RLYBRallybio Holdings LLC
09/05/202413:11Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLYBRallybio Holdings LLC
09/05/202413:00Business WireRallybio Reports First Quarter 2024 Financial Results and Provides Business UpdatesNASDAQ:RLYBRallybio Holdings LLC
07/05/202413:00Business WireRallybio to Present at the 2024 Citizens JMP Life Sciences ConferenceNASDAQ:RLYBRallybio Holdings LLC
17/04/202421:01Business WireFNAIT Systematic Literature Review and Meta-Analysis Presented at the Academy of Managed Care Pharmacy 2024 Annual MeetingNASDAQ:RLYBRallybio Holdings LLC
10/04/202421:01Business WireRallybio Announces Collaboration to Advance Therapeutic Solutions for Pregnant Individuals at Risk of Fetal and Neonatal Alloimmune Thrombocytopenia (FNAIT)NASDAQ:RLYBRallybio Holdings LLC
01/04/202415:05Business WireRallybio Announces FNAIT Systematic Literature Review to be Presented at the AMCP 2024 Annual MeetingNASDAQ:RLYBRallybio Holdings LLC
12/03/202412:00Business WireRallybio Reports Fourth Quarter and Full Year 2023 Financial ResultsNASDAQ:RLYBRallybio Holdings LLC
26/02/202413:00Business WireRallybio to Present at the TD Cowen 44th Annual Health Care ConferenceNASDAQ:RLYBRallybio Holdings LLC
16/02/202423:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:RLYBRallybio Holdings LLC
06/02/202413:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLYBRallybio Holdings LLC
06/02/202413:00Business WireRallybio Announces Portfolio Prioritization and Provides Corporate UpdateNASDAQ:RLYBRallybio Holdings LLC
04/01/202413:00Business WireRallybio Highlights Portfolio Advances and Outlines Expected Milestones in 2024NASDAQ:RLYBRallybio Holdings LLC
20/12/202313:15Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLYBRallybio Holdings LLC
20/12/202313:00Business WireRallybio Announces Preliminary Phase 1 Multiple Ascending Dose Data for RLYB116, an Innovative Subcutaneously Injected Inhibitor of Complement Component 5NASDAQ:RLYBRallybio Holdings LLC
09/12/202317:00Business WireRallybio Presents Natural History Study for Fetal and Neonatal Alloimmune Thrombocytopenia at the 65th American Society of Hematology Annual MeetingNASDAQ:RLYBRallybio Holdings LLC
28/11/202312:00Business WireRallybio Announces Preliminary Multiple Dose Data from the Completed Phase 1 Safety and Pharmacokinetics Study for RLYB212, an Anti-HPA-1a Monoclonal Antibody for the Prevention of Fetal and Neonatal Alloimmune ThrombocytopeniaNASDAQ:RLYBRallybio Holdings LLC
09/11/202321:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RLYBRallybio Holdings LLC
09/11/202321:10Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:RLYBRallybio Holdings LLC
09/11/202313:10Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:RLYBRallybio Holdings LLC
09/11/202313:00Business WireRallybio Reports Third Quarter 2023 Financial Results and Provides Business UpdatesNASDAQ:RLYBRallybio Holdings LLC
08/11/202313:00Business WireRallybio to Present at Upcoming Investor Conferences in NovemberNASDAQ:RLYBRallybio Holdings LLC
02/11/202313:15Business WireRallybio Announces Acceptance of FNAIT Natural History Study Abstract for Presentation at the 65th American Society of Hematology Annual MeetingNASDAQ:RLYBRallybio Holdings LLC
03/10/202313:00Business WireRallybio to Present at the JonesTrading 2023 Healthcare SummitNASDAQ:RLYBRallybio Holdings LLC
 Showing the most relevant articles for your search:NASDAQ:RLYB

Your Recent History

USOTC
OLCLY
Oriental Land (PK)
Delayed Upgrade Clock
    ADVFN Logo
    InvestorsHub

    United Kingdom
    Company
    Business
    Popular
    Get The App
    App Store
    Google Play

    Support: +44 (0) 203 8794 460 | support@advfn.com

    By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

    © 2024 ADVFN PLC - All Rights Reserved